Takeda Pharmaceutical Company Limited Interest Paid Classified As Financing Activities
Takeda Pharmaceutical Company Limited (TKPHF) reported Interest Paid Classified As Financing Activities of JPY 112.98 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:InterestPaidClassifiedAsFinancingActivities · last filed 2025-06-25
| Period end | Interest Paid Classified As Financing Activities 12 month |
|---|---|
| 2025-03-31 | 112.98B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 100.38B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 108.56B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 108.21B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 107.35B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 11.83B JPY 20-F · filed 2020-06-24 |
| 2019-03-31 | 4.64B JPY 20-F · filed 2020-06-24 |
| 2018-03-31 | 8.37B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 6.97B JPY 20-F · filed 2019-06-27 |